The Ramifications of HLA-B27

Schlosstein L. , Terasaki P.I. , Bluestone R. , Pearson C.M. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973; 288: 704–6

Brewerton D.A. , Hart F.D. , Nicholls A. , Caffrey M. , James D.C.O. , Sturrock R.D. Ankylosing spondylitis and HL-A27. Lancet 1973; 1: 904–7

Moll J.M.H. , Haslock I. , Macrae I.F. , Wright V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome. Medicine (Baltimore) 1974; 53: 343–64

Keat A.C. , Maini R.N. , Nkwazi G.C. , Pegrum G.D. , Ridgway G.L. , Scott J.T. Role of Chlamydia trachomatis and HLA-B27 in sexually acquired reactive arthritis. BMJ 1978; i: 605–7

Olivieri I. , Gemignani G. , Gherardi S. , Grassi L. , Ciompi M.L. Isolated HLA-B27 associated Achilles tendinitis. Ann Rheum Dis 1987; 46: 626–7

Feldman M. Southern Internal Medicine Conference: Whipple's disease. Am J Med Sci 1986; 291: 56–67

Yazici H. Behcet's syndrome. In: Maddison P.J. , Isenberg D.A. , Woo P. , Glass D.N. , eds. Oxford Textbook of Rheumatology, 2nd edn. Oxford: Oxford University Press, 1998: 1394–402

Khan A.K. A worldwide overview: the epidemiology of HLA-B27 and associated spondyloarthritides. In: Calin A. , Taurog J.D. , eds. The Spondylarthritides. Oxford: Oxford University Press, 1998: 17–26

Lau C.S. , Burgos-Vargas R. , Louthrenoo W. , Mok M.Y. , Wordsworth P. , Zeng Q.Y. Features of spondylarthritis around the world. Rheum Dis Clin N Am 1998; 24: 753–70

Khan M.A. , Ball E.J. Genetic aspects of ankylosing spondylitis. Best Tract Res Clin Rheumatol 2002; 16: 675–90

van der Linden S.M. , Valkenburg H.A. , de Jongh B.M. , Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984; 27: 241–9

Braun J. , Bollow M. , Remlinger G. . Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41: 58–67

Brown M.A. , Pile K.D. , Kennedy L.G. . A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum 1998; 41: 588–95

Brown M.A. , Kennedy L.G. , MacGregor A.J. . Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997; 40: 1823–8

Laval S.H. , Timms A. , Edwards S. . Whole genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001; 68: 918–26

Laval S.H. , Bradbury L. , Darke C. , Brophy S. , Calin A. , Brown M.A. The role of HLA-DR genes in ankylosing spondylitis complicating inflammatory bowel disease. Rheumatology 2000; 39(abstr suppl): A115

Hoyle E. , Laval S.H. , Calin A. , Wordsworth B.P. , Brown M.A. The X-chromosome and susceptibility to ankylosing spondylitis. Arthritis Rheum 2000; 43: 1353–5

Ebringer R.W. , Cawdell D.R. , Cowling P. , Ebringer A. Sequential studies in ankylosing spondylitis: association of Klebsiella pneumoniae with active disease. Ann Rheum Dis 1978; 37: 146–51

Saarinen M. , Ekman P. , Ikeda M. . Invasion of Salmonella into human intestinal epithelial cells is modulated by HLA-B27. Rheumatology 2002; 41: 651–7

Keat A. , Thomas B. , Dixey J. , Osborn M. , Sonnex C. , Taylor-Robinson D. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet 1987; i: 72–4

Lahesmaa-Rantala R. , Granfors K. , Isomaki H. , Toivanen A. Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis 1987; 46: 510–14

Bowness P. HLA B27 in health and disease: a double-edged sword? Rheumatology 2002; 41: 857–68

Bowness P. HLA and the spondylarthropathies. In: Lechler R. , Warrens A. , eds. HLA in Health and Disease, 2nd edn. San Diego: Academic Press, 2000: 187–94

Hammer R.E. , Maika S.D. , Richardson J.A. , Tang J.P. , Taurog J.D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990; 63: 1099–112

Cauli A. , Dessole G. , Fiorillo M.T. . Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology 2002; 41: 1375–9

Linssen A. , Rothova A. , Valkenburg H.A. The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci 1991; 32: 2568–78

Pulido J.S. , Streilein J.W. HLA and eye disease. In: Lechler R. , Warrens A. , eds. HLA in Health and Disease, 2nd edn. San Diego: Academic Press, 2000: 279–97

Rosenbaum J.T. Acute anterior uveitis and spondyloarthropathies. Rheum Dis Clin N Am 1992; 18: 143–50

Friedmann A. HLA and dermatological disease. In: Lechler R. , Warrens A. , eds. HLA in Health and Disease, 2nd edn. San Diego: Academic Press, 2000: 365–86

Rahman P. , Schentag C.T. , Gladman D.D. Immunogenetic profile of patients with psoriatic arthritis varies according to the age at onset of psoriasis. Arthritis Rheum 1999; 42: 822–3

Williamson L. , Dockerty J. , Dalbeth N. . Patterns of skin disease in psoriatic arthritis and associations with HLA-B27. Rheumatology 2002; 41(abstr suppl 1): A315

Merchant J.A. , Klouda P.T. , Soutar C.A. The HLA system in asbestos workers. BMJ 1975; i: 189–91

Evans C.C. , Lewinsohn H.C. , Evans J.M. Frequency of HLA antigen in asbestos workers with and without pulmonary fibrosis. BMJ 1977; i: 603–5

Huuskonen M.S. , Tiilikainen A. , Alanko K. HLA-B18 antigens and protection from pulmonary fibrosis in asbestos workers. Br J Dis Chest 1979; 73: 253–9

Hillerdal G. , Safvenberg J. HLA B27: a risk factor for lung disease? Lancet 1983; ii: 1195

Horslev-Petersen K. , Helin P. HLA-B27: a risk factor for lung disease? Lancet 1984; i: 104

Bergfeldt L. HLA-B27-associated cardiac disease. Ann Intern Med 1997; 127: 621–9

Au W.Y. , Hawkins B.R. , Cheng N. , Lie A.K.W. , Liang R. , Kwong Y.L. Risk of haematological malignancies in HLA-B27 carriers. Br J Haematol 2001; 115: 320–2

Njobvu P. , McGill P. , Kerr H. , Jellis J. , Pobee J. Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 1998; 25: 1553–9

Goulder P.J.R. , Phillips R.E. , Colbert R.A. . Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997; 3: 212–17

Khan M.A. , Khan M.K. Diagnostic value of HLA-B27 testing in ankylosing spondylitis and Reiter's syndrome. Ann Intern Med 1982; 96: 70–6

Amor B. , Dougados M. , Mijiyawa M. Critère diagnostique des spondylarthropathies. Rev Rheum Mal Osteoartic 1990; 57: 85–9

Brophy S. , Hamersma J. , Bradbury L. . Towards defining the genetic determinants of disease severity in ankylosing spondylitis. Rheumatology 2001; 40(abstr suppl 1): A48

Queiro R. , Belzunegui J. , Gonzalez C. , De Dios J.R. , Barastay E. , Figueroa M. The HLA-B27 antigen may determine the susceptibility to and the clinical expression of psoriatic spondyloarthropathy. Rheumatology 2001; 40(abstr suppl 1): A128

Leirisalo M. , Skylv G. , Kousa M. . Follow up study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982; 25: 249–59

Leirisalo-Repo M. , Helenius P. , Hannu T. . Long term prognosis of reactive salmonella arthritis. Ann Rheum Dis 1997; 56: 516–20

Bas S. , Kvien T.K. , Buchs N. , Fulpius T. , Gabay C. Lower level of synovial fluid interferon-γ in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis. Rheumatology 2003; 42: 461–7

Morris A.J. , Morris C.R. Is the presence of HLA B-27 a predisposing factor to poor outcomes in back surgery? Arthritis Rheum 1995; 38: 251

Jaraquemada D. , Ollier W. , Awad J. . HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis 1986; 45: 627–36

Ollier W. , Pepper L. , Thomson W. HLA-B27 as a marker for developing subluxations of the cervical spine in RA. Arthritis Rheum 1994; 37(suppl): A1017